Wilmington, Delaware, United States, Transparency Market Research Inc.: Cardiology stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis.
Wilmington, Delaware, United States, Transparency Market Research Inc.: Cardiology stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis. They are utilized in a procedure called percutaneous coronary intervention (PCI) or coronary angioplasty.
This procedure is a minimally invasive procedure to treat stenosis or narrowing of the coronary arteries. Technology plays an indispensable role in the global cardiology stents market. Manufacturers undertake rigorous research and development initiatives to develop nascent products that are functionally superior to their previous versions.
Key Drivers and Restraints of Global Cardiology Stents Market
Rise in number of dialysis centers across the world
- Changes in lifestyle and controlling rapidly rising obesity rate are major factors considered for the treatment of cardio vascular disease (CVD). Percutaneous coronary intervention has become a standard treatment option preferred across the globe for CVD.
- CVDs are listed as a major cause of mortality across the world, responsible for one in every three deaths in the U.S. According to the American Heart Association, coronary heart disease is a prominent cause of death, accounting for 45% of all the deaths in the U.S. occurring due to heart diseases each year.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77436
- Occurrence of restenosis after angioplasty procedure boosts the adoption of novel stents, such as drug-eluting and bioresorbable, which are known to drastically reduce the frequency of restenosis
- Increase in awareness about the technological innovations in interventional cardiology and cost effectiveness of the procedure propel stents production
Stringent Regulations for Product Approvals
- Approval of medical devices is considered to be expensive. Coronary stents fall under the category III devices of the U.S. FDA. These devices require submission and approval of pre-market approval (PMA) application prior to commercial marketing in the U.S.
- The requirements of clinical and pre-clinical data for stents engage the sponsor and manufacturer for a long period of time. Resources of manufacturers and investors such as time and money are spent on conducting safety testing and clinical pharmacology and toxicology testing of drug substance in case of DES. The FDA’s regulatory procedures are comparatively time-consuming as compared to that of EMA. Hence, commercialization of stents takes more time in the U.S. as compared to that in Europe.
- In 2011, Abbott Vascular received marketing approval for its first bioresorbable stent in Europe, while the same device received the FDA approval in the U.S. in 2016
- Hence, prolonged procedures of drug approval by regulatory authorities in the U.S. deter manufacturers from opting for development and commercialization of stents
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77436
Cardiology Stents Market: Segmentation
- In terms of product, the global cardiology stents market can be divided into bare metal stents, drug-eluting stents, bioresorbable stents, and others
- In terms of application, the global cardiology stents market can be split into coronary artery, carotid artery, iliac artery, and others
- Based on end-user, the global cardiology stents market can be segregated into hospitals, specialty clinics, and others
Asia Pacific Cardiology Stents Market to Expand at a Rapid Pace
- In terms of region, the global cardiology stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominates the global cardiology stents market, followed by Europe and Asia Pacific nations such as Japan and China. High geriatric population, lifestyle changes leading to obesity and related health complications, and the advent of advanced technologies such as bio-absorbable and next generation stents are major factors driving the global cardiology stents market.
- However, high cost of coronary stents, lack of reimbursement policies in some regions, and complications such as in-stent restenosis or thrombosis are major factors restraining the global market. However, novel technologies in clinical trials to address the unmet needs and emerging economies such as China, India, Brazil and others are likely to offer significant opportunities to manufacturers operating in the market.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77436
Leading Players Operating in Global Cardiology Stents Market
The global cardiology stents market was highly fragmented in 2019. Key players operating in the global cardiology stents market are:
- Abbott
- Boston Scientific Corporation
- BIOTRONIK AG
- Cardinal Health
- Cook Medical
- Lifetech Scientific
- Medtronic
- Terumo Corporation
More Trending Reports by Transparency Market Research –
AI in Drug Discovery Market: The AI in drug discovery market is estimated to expand at a CAGR of 36.1% during the forecast period of 2021-2031. The global market is projected to cross US$ 10.93 Bn by 2031.
Medical Holography Market: The global medical holography market was valued at around US$ 240.0 Mn in 2017 and is anticipated to reach around US$ 3500.0 Mn by 2026.
Self-sampling Blood Collection and Storage Devices Market: The self-sampling blood collection and storage devices market is slated to clock a CAGR of 11.9% from 2021 to 2031.
Home Diagnostics Market: The global home diagnostics market is projected to expand at a CAGR of 4.4% from 2021 to 2031.
Laboratory Temperature Control Units Market: The global laboratory temperature control units market is projected to expand at a moderate CAGR of 5.4% from 2021 to 2031.
Single Use Cystoscope Market: The global single use cystoscope market was valued at US$ 95 Mn in 2020 and is anticipated to expand at a CAGR of 4.5% from 2021 to 2031.
Healthcare Informatics Market: The global healthcare informatics market is projected to advance at a robust CAGR of ~12% during the forecast period.
Suture Anchors Market: The global suture anchors market was valued at US$ 0.6 Bn in 2020 and is anticipated to expand at a CAGR of ~5% from 2021 to 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com